BioNTech has lifted its revenue forecast for its blockbuster coronavirus vaccine to €17bn this year as demand for the jab continues to grow.
BioNTech将其畅销新冠疫苗今年全年的营收预测上调至170亿欧元。目前manbetx app苹果
对这款疫苗的需求持续增长。
您已阅读6%（192字），剩余94%（3164字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。